Molecular Partners AG ADR (MOLN): Next-Year EPS Estimate 28.99%
As of 2026-06-04, Molecular Partners AG ADR (MOLN) has a next-year EPS growth estimate of 28.99%.
On 2026-05-14, analyst consensus for MOLN's next-year EPS growth shifted from 28.98% to 28.99% — a positive change of 0.01 percentage points. The revised estimate has been sustained across 16 subsequent trading sessions. Current-year growth is projected at 22.49%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 28.99%
- EPS growth this year
- 22.49%
- EPS next quarter (est)
- -$0.43
- Last price
- $3.93
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 28.99% | 22.49% | -$0.43 | $3.93 |
| 2026-06-03 | 28.99% | 22.49% | -$0.43 | $4.03 |
| 2026-06-02 | 28.99% | 22.49% | -$0.43 | $3.92 |
| 2026-06-01 | 28.99% | 22.49% | -$0.43 | $3.95 |
| 2026-05-31 | 28.99% | 22.49% | -$0.43 | $4.20 |
| 2026-05-28 | 28.99% | 22.49% | -$0.43 | $4.00 |
| 2026-05-27 | 28.99% | 22.49% | -$0.43 | $4.04 |
| 2026-05-26 | 28.99% | 22.49% | -$0.43 | $4.05 |
| 2026-05-25 | 28.99% | 22.49% | -$0.43 | $4.18 |
| 2026-05-24 | 28.99% | 22.49% | -$0.43 | $4.18 |
| 2026-05-21 | 28.99% | 22.49% | -$0.43 | $3.80 |
| 2026-05-20 | 28.99% | 22.49% | -$0.43 | $3.74 |
| 2026-05-19 | 28.99% | 22.49% | -$0.43 | $3.74 |
| 2026-05-18 | 28.99% | 22.49% | -$0.43 | $3.80 |
| 2026-05-17 | 28.99% | 22.49% | -$0.43 | $3.84 |
| 2026-05-14 | 28.99% | 22.49% | -$0.43 | $3.84 |
| 2026-05-13 | 28.98% | 22.51% | -$0.43 | $4.02 |
| 2026-05-12 | 34.42% | 25.95% | -$0.42 | $4.04 |
| 2026-05-11 | 26.51% | 23.79% | -$0.42 | $4.13 |
| 2026-05-10 | 26.51% | 23.79% | -$0.42 | $4.10 |
| 2026-05-07 | 26.51% | 23.79% | -$0.42 | $4.10 |
| 2026-05-06 | 26.51% | 23.79% | -$0.42 | $4.29 |
| 2026-05-05 | 26.51% | 23.79% | -$0.42 | $4.25 |
| 2026-05-04 | 26.51% | 23.79% | -$0.42 | $4.41 |
| 2026-05-03 | 26.51% | 23.79% | -$0.42 | $4.24 |
| 2026-04-30 | 26.51% | 23.79% | -$0.42 | $4.23 |
| 2026-04-29 | 26.51% | 23.79% | -$0.42 | $4.45 |
| 2026-04-28 | 26.51% | 23.79% | -$0.42 | $4.28 |
| 2026-04-27 | 26.51% | 23.79% | -$0.42 | $4.35 |
| 2026-04-26 | 26.51% | 23.79% | -$0.42 | $4.46 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Molecular Partners AG ADR's next-year EPS growth estimate?▾
As of 2026-06-04, Molecular Partners AG ADR (MOLN) has a next-year EPS growth estimate of 28.99%, based on analyst consensus.
When was the latest EPS estimate revision for MOLN?▾
The most recent revision occurred on 2026-05-14, when analysts adjusted the next-year EPS growth estimate from 28.98% to 28.99%.
What sector and industry does Molecular Partners AG ADR belong to?▾
Molecular Partners AG ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. MOLN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Molecular Partners AG ADR (MOLN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports